TechNet-21 - Forum

  1. Géraldine Nemrod
  2. Supply chain and logistics
  3. Friday, 10 June 2022

Join us in the next webinar session in our series on Strengthening immunization supply chains with the Effective Vaccine Management (EVM) assessment tool.

EVM is a global initiative to increase immunization coverage through the continuous improvement of vaccine supply chains, ensuring potent, life-saving vaccines are available to vaccinate populations through the life course when and where they’re needed. EVM was launched in 2009. Drawing on lessons learnt conducting EVM assessments in more than 80 countries, and by leveraging developments in mobile and cloud-based computing, EVM2 was released in 2019. The new tool builds upon the original to provide countries with a broader, more powerful, more agile and more sustainable solution for improving immunization supply chain systems. For more information on EVM, visit the EVM website.

 

- EN session: Developing, implementing and validating a successful continuous improvement plan (cIP)

Date: 16 June, 15:00 CEST

Register here: https://who.zoom.us/webinar/register/WN_4hEeHyBkSXulhucc4SD6-A (FR interpretation available)

 

- Session FR: Élaborer, mettre en œuvre et valider un plan d'amélioration continue (cIP) réussi

Date: 21 juin, 15:00 CEST

Inscription: https://who.zoom.us/webinar/register/WN_INT8rvBfSUuVVzs-AOnsFQ

 

 

Accepted Answer Pending Moderation

The materials of our webinar session ‘Developing and implementing a continuous improvement plan (cIP)’, are now available:

 

 - EN session: Developing, implementing and validating a successful continuous improvement plan (cIP)

- Session FR: Développer et mettre en œuvre un plan d'amélioration continue (PAC)

For more resources on EVM, and for all the recordings and presentations of this webinar series, please visit our dedicated topic page: https://www.technet-21.org/en/topics/evm

  1. more than a month ago
  2. Supply chain and logistics
  3. # 1
  • Page :
  • 1


There are no replies made for this post yet.
Be one of the first to reply to this post!